News & Updates
Showing Multidisciplinary articles
Showing

Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
A programme targeting 9,000 adults 18–44 years of age will identify individuals with high 10-year risk of diabetes through DNA testing and provide precision preventive intervention.
Young-onset diabetes programme provides DNA testing and precision preventive intervention to those at risk
07 Nov 2025
Datopotamab deruxtecan improves survival in breast cancer patients not eligible for immunotherapy
First-line treatment with datopotamab deruxtecan (Dato-DXd) results in statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) compared with chemotherapy in patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), as shown by the results of the phase III TROPION-Breast02 trial.
Datopotamab deruxtecan improves survival in breast cancer patients not eligible for immunotherapy
06 Nov 2025
High BMI tied to ulnar nerve entrapment development in nondiabetic individuals
A longitudinal study from Sweden shows an association between high BMI and the development of ulnar nerve entrapment (UNE) in a middle-aged cohort of individuals without diabetes from northern Europe, with over 25 years of follow-up.






